Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-β-mediated induction of the CDK inhibitor p15Ink4B

Molecular Cell

Volumn 9, Issue 1, 2002, Pages 133-143

  Feng, Xin Hua ^a   Liang, Yao Yun ^a   Liang, Min ^a   Zhai, Weiguo ^b   Lin, Xia ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH FACTOR; PROTEIN P15; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CELL CULTURE; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; ONCOGENE; ONCOGENE C MYC; PROMOTER REGION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 0036159130     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(01)00430-0     Document Type: Article

References (51)

1. A combination treatment of c-myc antisense DNA with all-transretinoic acid inhibits cell proliferation by downregulating c-myc expression in small cell lung cancer
2. Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of TGFβ1
3. Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma
4. Role of TGFβ in human disease
5. Cooperation of E2F-p130 and Sp1-pRb complexes in repression of the Chinese hamster dhfr gene
6. Inaugural article: Defective repression of c-myc in breast cancer cells: A loss at the core of the TGFβ growth arrest program
7. Molecular therapy with recombinant antisense c-myc adenovirus for human gastric carcinoma cells in vitro and in vivo
8. Myc-mediated transformation: The repression connection
9. CIP1 by c-Myc in overcoming TGFβ-induced cell-cycle arrest
10. The Myc oncoprotein: A critical evaluation of transactivation and target gene regulation
11. Inhibition of c-myc expression in cells by targeting an RNA-protein interaction using antisense oligonucleotides
12. c-Myc target genes involved in cell growth, apoptosis, and metabolism
13. TGFβ induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism
14. TGF-β receptor signaling
15. Smads: Transcriptional activators of TGF-β responses
16. Histone deacetylase 1 can repress transcription by binding to Sp1
17. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
18. TGF-β-induced down-regulation of cyclin A expression requires a functional TGF-β receptor complex. Characterization of chimeric and truncated type I and type II receptors
19. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation
20. Ink4B transcription in response to TGF-β
21. Myc represses the p21 promoter and interacts with Sp1/Sp3
22. Cdi1, a human G1 and S phase protein phosphatase that associates with CDK2
23. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
24. The hallmarks of cancer
25. ink4B is a potential effector of TGF-β-induced cell cycle arrest
26. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15
27. Molecular mechanisms of inactivation of TGF-β receptors during carcinogenesis
28. Potential role of WAF1/Cip1/p21 as a mediator of TGF-β cytoinhibitory effect
29. INK4B through an Sp1 consensus site
30. TGF-β receptors and DNA repair genes, coupled targets in a pathway of human colon carcinogenesis
31. Controlling TGF-β signaling
32. Transcriptional control by the TGF-β/Smad signaling system
33. TGF-β signaling in growth control, cancer, and heritable disorders
34. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members
35. MYC oncogenes and human neoplastic disease
36. WAF1/Cip1 regulation by TGF-β
37. Specificity, diversity, and regulation in TGF-β superfamily signaling
38. Kip/Cip and Ink4 cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β
39. INK4B induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines
40. Frequency of Smad gene mutations in human cancers
41. Peptide growth factors and their receptors
42. New Myc-interacting proteins: A second Myc network emerges
43. INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells
44. DPC4 gene in various tumor types
45. INK4b
46. INK4b expression by Myc through association with Miz-1
47. Antitumor effects of antisense phosphorothioate c-myc oligodeoxynucleotides: A question of mechanism
48. p53-independent role of MDM2 in TGF-β resistance
49. Myc downregulation by TGF-β required for activation of the p15 G1 arrest pathway
50. The Smad pathway
51. Early gene responses to TGF-β in cells lacking growth-suppressive RB function